AU2021900212A0 - Sars-CoV-2 vaccine antigens - Google Patents

Sars-CoV-2 vaccine antigens

Info

Publication number
AU2021900212A0
AU2021900212A0 AU2021900212A AU2021900212A AU2021900212A0 AU 2021900212 A0 AU2021900212 A0 AU 2021900212A0 AU 2021900212 A AU2021900212 A AU 2021900212A AU 2021900212 A AU2021900212 A AU 2021900212A AU 2021900212 A0 AU2021900212 A0 AU 2021900212A0
Authority
AU
Australia
Prior art keywords
cov
sars
vaccine antigens
vaccine
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021900212A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Griffith University
Original Assignee
Griffith University
Filing date
Publication date
Application filed by Griffith University filed Critical Griffith University
Publication of AU2021900212A0 publication Critical patent/AU2021900212A0/en
Priority to PCT/AU2022/050050 priority Critical patent/WO2022160017A1/en
Abandoned legal-status Critical Current

Links

AU2021900212A 2021-02-01 2021-02-01 Sars-CoV-2 vaccine antigens Abandoned AU2021900212A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2022/050050 WO2022160017A1 (en) 2021-02-01 2022-02-01 Sars-cov-2 vaccine antigens

Publications (1)

Publication Number Publication Date
AU2021900212A0 true AU2021900212A0 (en) 2021-02-18

Family

ID=

Similar Documents

Publication Publication Date Title
EP3796927A4 (en) Shared antigens
GB202002166D0 (en) Vaccine
EP4213872A4 (en) Piv5-based covid-19 vaccine
EP4159234A4 (en) Sars-cov-2 vaccine
EP3740497A4 (en) Enhanced immunogenicity for gpi-anchored antigens
EP3903810A4 (en) Preparation including vaccine adjuvant
EP3747459A4 (en) Novel vaccine immunoadjuvant
EP3730620A4 (en) Cross-immunizing antigen vaccine and method for preparation thereof
EP3941219A4 (en) Saponin-based vaccine adjuvants
EP3866847A4 (en) Virus vaccine
AU2021900212A0 (en) Sars-CoV-2 vaccine antigens
AU2021902530A0 (en) Vaccine Antigen
AU2021902500A0 (en) Vaccine Antigen
AU2023902599A0 (en) Vaccine Antigen
GB202016954D0 (en) Vaccine
EP3923981A4 (en) Vaccine adjuvants and formulations
AU2021903076A0 (en) SARS-CoV2 Vaccine
GB202009414D0 (en) Vaccine antigens
GB202306776D0 (en) Immunogenic antigens
EP3820997A4 (en) Viral-vectored vaccine for malaria
AU2019903260A0 (en) Cancer vaccine
AU2019903753A0 (en) Malaria vaccines
AU2023300396A1 (en) Epstein-barr-virus vaccine
EP4065595A4 (en) Immunogenic protein against gonococcal infection
EP3794106A4 (en) Parasite vaccine